-
Dordaviprone Receives Accelerated FDA Approval for Diffuse Midline Glioma
06 Aug 2025 21:48 GMT
… 5 nonrandomized clinical trials involving 50 patients … benefit in confirmatory trial(s).
The mechanism … ClpP) agonist and a dopamine receptor D2 (DRD2) antagonist … FDA acceptance and priority review of new drug application for dordaviprone as treatment …
-
Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
07 Aug 2025 01:14 GMT
… Food and Drug Administration (FDA) for the treatment of adult … ClpP) and also inhibits dopamine D2 receptor (DRD2). … and initiate appropriate medical treatment and supportive care. … information.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ …
-
FDA Grants Accelerated Approval to Dordaviprone for H3 K27M-Mutated Diffuse Glioma
06 Aug 2025 19:22 GMT
… weight.
Trial Inclusion Criteria
Patients enrolled in the trials had received … period from previous oncologic treatment. They also had a … drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma
ONC201 dordaviprone. Jazz Pharmaceuticals …
-
1ST Bio and D&D Pharmatech win US patent for disease-modifying Parkinson’s drug
06 Aug 2025 16:24 GMT
… , the companies said Wednesday.
The drug targets RIPK2, a signaling protein … , NLY02 reduced inflammation and protected dopamine-producing neurons, which the companies … ongoing partnership discussions with global pharmaceutical firms.
-
Cingulate Submits New Drug Application To FDA For Lead ADHD Asset Ctx-1301
06 Aug 2025 14:04 GMT
… Precision Timed ReleaseTM (PTRTM) drug delivery platform technology to build … pharmaceutical ingredient dexmethylphenidate, a compound approved by the FDA for the treatment … stimulant class of medicines and increases norepinephrine and dopamine activity in …
-
Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301
06 Aug 2025 12:45 GMT
… Precision Timed Release™ (PTR™) drug delivery platform technology to build … pharmaceutical ingredient dexmethylphenidate, a compound approved by the FDA for the treatment … stimulant class of medicines and increases norepinephrine and dopamine activity in …
-
Davenport wellness clinic to unveil non-invasive, breakthrough mental health treatment at free open house
06 Aug 2025 12:34 GMT
… without medications or downtime.
About EXOMIND
EXOMIND is an FDA-approved … neurotransmitters like dopamine and serotonin using a non-invasive, medication-free approach … to improving clarity, calm, and energy.
Treatments are …
-
Ask the doctors: Discussing radon, Parkinson’s and musty smells
06 Aug 2025 08:52 GMT
… .D.
Andrews McMeel Syndication
Dear Doctors: My ex-husband had a … result in a deficit of dopamine, a neurotransmitter crucial to smooth … movement. The steady decrease in dopamine production causes the primary symptoms …
-
Pediatric research: how to fix a clinical trial system built for adults
06 Aug 2025 06:15 GMT
… therapy, unexpected responses, adverse drug reactions and toxicity. Significantly … 2000s with the Best Pharmaceuticals for Children Act … during clinical trials. These include ensuring that all medical devices, … patients thanks to the dopamine hits and positive …
-
Commentary: Dopamine Is Not Why Kids Love TikTok
04 Aug 2025 21:30 GMT
… cheeky paper used the standard medical criteria to show young … that do not rely on pharmaceutical effects. This has been … the safety of vaccines, the popularity of the dopamine myth amounts … in activation of dopamine for addictive drugs versus pleasant and …